(Q40587138)

21 September 2017

1 reference

title

Rheumatoid arthritis: new approaches for its evaluation and management (English)

1 reference

21 September 2017

1 reference

Semble EL

1

1 reference

21 September 2017

language of work or name

1 reference

1 February 1995

1 reference

Archives of Physical Medicine and Rehabilitation

21 September 2017

published in

1 reference

21 September 2017

volume

76

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

190-201

1 reference

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Acute infectious arthritis. A review of patients with nongonococcal joint infections (with emphasis on therapy and prognosis)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Human parvovirus B19 arthropathy in two adults after contact with childhood erythema infectiosum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Still's disease in the adult

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

An electronic method for measuring joint tenderness in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

The relation of radiographic changes to serum acute-phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Efficacy of tests used to monitor rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Prospective study of the early course of rheumatoid arthritis in young adults: Comparison of patients with and without rheumatoid factor positivity at entry and identification of variables correlating with outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Onset, early stages, and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Long-term outcome of treating rheumatoid arthritis: results after 20 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Sensitivity of Radiographic Changes of Hand and Foot Joints as a Diagnostic Criterion in Patients with Rheumatoid Arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

The radiographic criterion in the 1987 revised criteria for rheumatoid arthritis. Reassessment in a prospective study of early disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Magnetic resonance imaging in patients with inflammatory arthritis of the knee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

MRI of the cervical spine: Rheumatoid arthritis compared with cervical spondylosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Predictive value of radionuclide joint scintigrams

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Therapeutic criteria in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Measuring health status in arthritis. The arthritis impact measurement scales.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

AIMS2. The Content and Properties of a Revised and Expanded Arthritis Impact Measurement Scales Health Status Questionnaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Measurement of patient outcome in arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Measurement of functional status, quality of life, and utility in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Comprehensive outpatient care in rheumatoid arthritis. A controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Substantial work disability and earnings losses in individuals less than age 65 with osteoarthritis: Comparisons with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Work disability in rheumatoid arthritis: effects of disease, social, and work factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

A comparison of disability measured by the Stanford Health Assessment Questionnaire disability scales (HAQ) in male and female rheumatoid outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Early rheumatoid arthritis--onset, course, and outcome over 2 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Formal education as a marker for increased mortality and morbidity in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Occupation, income, and education as independent covariates of arthritis in four national probability samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

The importance of age, education, and comorbidity in the substantial earnings losses of individuals with symmetric polyarthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Cost-effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Comprehensive management of patients with rheumatoid arthritis. Some results of the regional Arthritis Control Program in Michigan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Antiinflammatory drugs and gastric mucosal damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Renal Effects of Prostaglandins and Clinical Adverse Effects of Nonsteroidal Anti-Inflammatory Agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Salsalate in the treatment of rheumatoid arthritis: a double-blind clinical and gastroscopic trial versus piroxicam. II. Endoscopic evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Preclinical overview of nabumetone. Pharmacology, bioavailability, metabolism, and toxicology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

A cost-utility analysis of misoprostol prophylaxis for rheumatoid arthritis patients receiving nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Implications of nonsteroidal anti-inflammatory drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Diclofenac-associated hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Cognitive dysfunction associated with naproxen and ibuprofen in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Methotrexate in rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Osteopenia in patients with rheumatic diseases: principles of diagnosis and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Does steroid pulsing influence the efficacy and toxicity of chrysotherapy? A double blind, placebo controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Plasmapheresis and lymphoplasmapheresis in the management of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Monoclonal antibody treatment in rheumatoid arthritis: the clinical and immunological effects of a CD7 monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Cyclosporin A treatment of refractory rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Cyclosporin A in severe, treatment-refractory rheumatoid arthritis. A randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Efficacy of physical conditioning exercise in patients with rheumatoid arthritis and osteoarthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Essentials of physical management and rehabilitation in arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Diet therapy for rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

The controversy over zinc sulphate efficacy in rheumatoid and psoriatic arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Treatment of rheumatoid arthritis with gammalinolenic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Arthritis patient education: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Correlates of community resource information needs of arthritis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

Long-term outcome of rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-9993%2895%2980029-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0003-9993(95)80029-8

1 reference

21 September 2017

1 reference